Toll Free: 1-888-928-9744
Published: Jun, 2018 | Pages:
108 | Publisher: QYResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
In this report, the Asia-Pacific Neurological Disorder Drugs market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Neurological Disorder Drugs for these regions, from 2013 to 2025 (forecast), including • China • Japan • South Korea • Taiwan • India • Southeast Asia • Australia Asia-Pacific Neurological Disorder Drugs market competition by top manufacturers/players, with Neurological Disorder Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including • Novartis AG • GlaxoSmithKline plc • Merck & Co. • Bayer AG • AstraZeneca • Boehringer Ingelheim GmbH • Teva Pharmaceutical Industries Ltd. On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into • Antipsychotic • Hypnotic & Sedative • Analgesics • Anticoagulants • Others On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including • Hospital • Clinic • Home
Table of Contents Asia-Pacific Neurological Disorder Drugs Market Report 2018 1 Neurological Disorder Drugs Overview 1.1 Product Overview and Scope of Neurological Disorder Drugs 1.2 Classification of Neurological Disorder Drugs by Product Category 1.2.1 Asia-Pacific Neurological Disorder Drugs Market Size (Sales) Comparison by Types (2013-2025) 1.2.2 Asia-Pacific Neurological Disorder Drugs Market Size (Sales) Market Share by Type (Product Category) in 2017 1.2.3 Antipsychotic 1.2.4 Hypnotic & Sedative 1.2.5 Analgesics 1.2.6 Anticoagulants 1.2.7 Others 1.3 Asia-Pacific Neurological Disorder Drugs Market by Application/End Users 1.3.1 Asia-Pacific Neurological Disorder Drugs Sales (Volume) and Market Share Comparison by Applications (2013-2025) 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Home 1.4 Asia-Pacific Neurological Disorder Drugs Market by Region 1.4.1 Asia-Pacific Neurological Disorder Drugs Market Size (Value) Comparison by Region (2013-2025) 1.4.2 China Status and Prospect (2013-2025) 1.4.3 Japan Status and Prospect (2013-2025) 1.4.4 South Korea Status and Prospect (2013-2025) 1.4.5 Taiwan Status and Prospect (2013-2025) 1.4.6 India Status and Prospect (2013-2025) 1.4.7 Southeast Asia Status and Prospect (2013-2025) 1.4.8 Australia Status and Prospect (2013-2025) 1.5 Asia-Pacific Market Size (Value and Volume) of Neurological Disorder Drugs (2013-2025) 1.5.1 Asia-Pacific Neurological Disorder Drugs Sales and Growth Rate (2013-2025) 1.5.2 Asia-Pacific Neurological Disorder Drugs Revenue and Growth Rate (2013-2025) 2 Asia-Pacific Neurological Disorder Drugs Competition by Players/Suppliers, Region, Type and Application 2.1 Asia-Pacific Neurological Disorder Drugs Market Competition by Players/Suppliers 2.1.1 Asia-Pacific Neurological Disorder Drugs Sales Volume and Market Share of Key Players/Suppliers (2013-2018) 2.1.2 Asia-Pacific Neurological Disorder Drugs Revenue and Share by Players/Suppliers (2013-2018) 2.2 Asia-Pacific Neurological Disorder Drugs (Volume and Value) by Type 2.2.1 Asia-Pacific Neurological Disorder Drugs Sales and Market Share by Type (2013-2018) 2.2.2 Asia-Pacific Neurological Disorder Drugs Revenue and Market Share by Type (2013-2018) 2.3 Asia-Pacific Neurological Disorder Drugs (Volume) by Application 2.4 Asia-Pacific Neurological Disorder Drugs (Volume and Value) by Region 2.4.1 Asia-Pacific Neurological Disorder Drugs Sales and Market Share by Region (2013-2018) 2.4.2 Asia-Pacific Neurological Disorder Drugs Revenue and Market Share by Region (2013-2018) 3 China Neurological Disorder Drugs (Volume, Value and Sales Price) 3.1 China Neurological Disorder Drugs Sales and Value (2013-2018) 3.1.1 China Neurological Disorder Drugs Sales Volume and Growth Rate (2013-2018) 3.1.2 China Neurological Disorder Drugs Revenue and Growth Rate (2013-2018) 3.1.3 China Neurological Disorder Drugs Sales Price Trend (2013-2018) 3.2 China Neurological Disorder Drugs Sales Volume and Market Share by Type 3.3 China Neurological Disorder Drugs Sales Volume and Market Share by Application 4 Japan Neurological Disorder Drugs (Volume, Value and Sales Price) 4.1 Japan Neurological Disorder Drugs Sales and Value (2013-2018) 4.1.1 Japan Neurological Disorder Drugs Sales Volume and Growth Rate (2013-2018) 4.1.2 Japan Neurological Disorder Drugs Revenue and Growth Rate (2013-2018) 4.1.3 Japan Neurological Disorder Drugs Sales Price Trend (2013-2018) 4.2 Japan Neurological Disorder Drugs Sales Volume and Market Share by Type 4.3 Japan Neurological Disorder Drugs Sales Volume and Market Share by Application 5 South Korea Neurological Disorder Drugs (Volume, Value and Sales Price) 5.1 South Korea Neurological Disorder Drugs Sales and Value (2013-2018) 5.1.1 South Korea Neurological Disorder Drugs Sales Volume and Growth Rate (2013-2018) 5.1.2 South Korea Neurological Disorder Drugs Revenue and Growth Rate (2013-2018) 5.1.3 South Korea Neurological Disorder Drugs Sales Price Trend (2013-2018) 5.2 South Korea Neurological Disorder Drugs Sales Volume and Market Share by Type 5.3 South Korea Neurological Disorder Drugs Sales Volume and Market Share by Application 6 Taiwan Neurological Disorder Drugs (Volume, Value and Sales Price) 6.1 Taiwan Neurological Disorder Drugs Sales and Value (2013-2018) 6.1.1 Taiwan Neurological Disorder Drugs Sales Volume and Growth Rate (2013-2018) 6.1.2 Taiwan Neurological Disorder Drugs Revenue and Growth Rate (2013-2018) 6.1.3 Taiwan Neurological Disorder Drugs Sales Price Trend (2013-2018) 6.2 Taiwan Neurological Disorder Drugs Sales Volume and Market Share by Type 6.3 Taiwan Neurological Disorder Drugs Sales Volume and Market Share by Application 7 India Neurological Disorder Drugs (Volume, Value and Sales Price) 7.1 India Neurological Disorder Drugs Sales and Value (2013-2018) 7.1.1 India Neurological Disorder Drugs Sales Volume and Growth Rate (2013-2018) 7.1.2 India Neurological Disorder Drugs Revenue and Growth Rate (2013-2018) 7.1.3 India Neurological Disorder Drugs Sales Price Trend (2013-2018) 7.2 India Neurological Disorder Drugs Sales Volume and Market Share by Type 7.3 India Neurological Disorder Drugs Sales Volume and Market Share by Application 8 Southeast Asia Neurological Disorder Drugs (Volume, Value and Sales Price) 8.1 Southeast Asia Neurological Disorder Drugs Sales and Value (2013-2018) 8.1.1 Southeast Asia Neurological Disorder Drugs Sales Volume and Growth Rate (2013-2018) 8.1.2 Southeast Asia Neurological Disorder Drugs Revenue and Growth Rate (2013-2018) 8.1.3 Southeast Asia Neurological Disorder Drugs Sales Price Trend (2013-2018) 8.2 Southeast Asia Neurological Disorder Drugs Sales Volume and Market Share by Type 8.3 Southeast Asia Neurological Disorder Drugs Sales Volume and Market Share by Application 9 Australia Neurological Disorder Drugs (Volume, Value and Sales Price) 9.1 Australia Neurological Disorder Drugs Sales and Value (2013-2018) 9.1.1 Australia Neurological Disorder Drugs Sales Volume and Growth Rate (2013-2018) 9.1.2 Australia Neurological Disorder Drugs Revenue and Growth Rate (2013-2018) 9.1.3 Australia Neurological Disorder Drugs Sales Price Trend (2013-2018) 9.2 Australia Neurological Disorder Drugs Sales Volume and Market Share by Type 9.3 Australia Neurological Disorder Drugs Sales Volume and Market Share by Application 10 Asia-Pacific Neurological Disorder Drugs Players/Suppliers Profiles and Sales Data 10.1 Novartis AG 10.1.1 Company Basic Information, Manufacturing Base and Competitors 10.1.2 Neurological Disorder Drugs Product Category, Application and Specification 10.1.2.1 Product A 10.1.2.2 Product B 10.1.3 Novartis AG Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2013-2018) 10.1.4 Main Business/Business Overview 10.2 GlaxoSmithKline plc 10.2.1 Company Basic Information, Manufacturing Base and Competitors 10.2.2 Neurological Disorder Drugs Product Category, Application and Specification 10.2.2.1 Product A 10.2.2.2 Product B 10.2.3 GlaxoSmithKline plc Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2013-2018) 10.2.4 Main Business/Business Overview 10.3 Merck & Co. 10.3.1 Company Basic Information, Manufacturing Base and Competitors 10.3.2 Neurological Disorder Drugs Product Category, Application and Specification 10.3.2.1 Product A 10.3.2.2 Product B 10.3.3 Merck & Co. Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2013-2018) 10.3.4 Main Business/Business Overview 10.4 Bayer AG 10.4.1 Company Basic Information, Manufacturing Base and Competitors 10.4.2 Neurological Disorder Drugs Product Category, Application and Specification 10.4.2.1 Product A 10.4.2.2 Product B 10.4.3 Bayer AG Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2013-2018) 10.4.4 Main Business/Business Overview 10.5 AstraZeneca 10.5.1 Company Basic Information, Manufacturing Base and Competitors 10.5.2 Neurological Disorder Drugs Product Category, Application and Specification 10.5.2.1 Product A 10.5.2.2 Product B 10.5.3 AstraZeneca Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2013-2018) 10.5.4 Main Business/Business Overview 10.6 Boehringer Ingelheim GmbH 10.6.1 Company Basic Information, Manufacturing Base and Competitors 10.6.2 Neurological Disorder Drugs Product Category, Application and Specification 10.6.2.1 Product A 10.6.2.2 Product B 10.6.3 Boehringer Ingelheim GmbH Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2013-2018) 10.6.4 Main Business/Business Overview 10.7 Teva Pharmaceutical Industries Ltd. 10.7.1 Company Basic Information, Manufacturing Base and Competitors 10.7.2 Neurological Disorder Drugs Product Category, Application and Specification 10.7.2.1 Product A 10.7.2.2 Product B 10.7.3 Teva Pharmaceutical Industries Ltd. Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2013-2018) 10.7.4 Main Business/Business Overview 11 Neurological Disorder Drugs Manufacturing Cost Analysis 11.1 Neurological Disorder Drugs Key Raw Materials Analysis 11.1.1 Key Raw Materials 11.1.2 Price Trend of Key Raw Materials 11.1.3 Key Suppliers of Raw Materials 11.1.4 Market Concentration Rate of Raw Materials 11.2 Proportion of Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Manufacturing Process Analysis of Neurological Disorder Drugs 12 Industrial Chain, Sourcing Strategy and Downstream Buyers 12.1 Neurological Disorder Drugs Industrial Chain Analysis 12.2 Upstream Raw Materials Sourcing 12.3 Raw Materials Sources of Neurological Disorder Drugs Major Manufacturers in 2017 12.4 Downstream Buyers 13 Marketing Strategy Analysis, Distributors/Traders 13.1 Marketing Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.1.3 Marketing Channel Development Trend 13.2 Market Positioning 13.2.1 Pricing Strategy 13.2.2 Brand Strategy 13.2.3 Target Client 13.3 Distributors/Traders List 14 Market Effect Factors Analysis 14.1 Technology Progress/Risk 14.1.1 Substitutes Threat 14.1.2 Technology Progress in Related Industry 14.2 Consumer Needs/Customer Preference Change 14.3 Economic/Political Environmental Change 15 Asia-Pacific Neurological Disorder Drugs Market Forecast (2018-2025) 15.1 Asia-Pacific Neurological Disorder Drugs Sales Volume, Revenue and Price Forecast (2018-2025) 15.1.1 Asia-Pacific Neurological Disorder Drugs Sales Volume and Growth Rate Forecast (2018-2025) 15.1.2 Asia-Pacific Neurological Disorder Drugs Revenue and Growth Rate Forecast (2018-2025) 15.1.3 Asia-Pacific Neurological Disorder Drugs Price and Trend Forecast (2018-2025) 15.2 Asia-Pacific Neurological Disorder Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025) 15.2.1 Asia-Pacific Neurological Disorder Drugs Sales Volume and Growth Rate Forecast by Region (2018-2025) 15.2.2 Asia-Pacific Neurological Disorder Drugs Revenue and Growth Rate Forecast by Region (2018-2025) 15.2.3 China Neurological Disorder Drugs Sales, Revenue and Growth Rate Forecast (2018-2025) 15.2.4 Japan Neurological Disorder Drugs Sales, Revenue and Growth Rate Forecast (2018-2025) 15.2.5 South Korea Neurological Disorder Drugs Sales, Revenue and Growth Rate Forecast (2018-2025) 15.2.6 Taiwan Neurological Disorder Drugs Sales, Revenue and Growth Rate Forecast (2018-2025) 15.2.7 India Neurological Disorder Drugs Sales, Revenue and Growth Rate Forecast (2018-2025) 15.2.8 Southeast Asia Neurological Disorder Drugs Sales, Revenue and Growth Rate Forecast (2018-2025) 15.2.9 Australia Neurological Disorder Drugs Sales, Revenue and Growth Rate Forecast (2018-2025) 15.3 Asia-Pacific Neurological Disorder Drugs Sales, Revenue and Price Forecast by Type (2018-2025) 15.3.1 Asia-Pacific Neurological Disorder Drugs Sales Forecast by Type (2018-2025) 15.3.2 Asia-Pacific Neurological Disorder Drugs Revenue Forecast by Type (2018-2025) 15.3.3 Asia-Pacific Neurological Disorder Drugs Price Forecast by Type (2018-2025) 15.4 Asia-Pacific Neurological Disorder Drugs Sales Forecast by Application (2018-2025) 16 Research Findings and Conclusion 17 Appendix 17.1 Methodology/Research Approach 17.1.1 Research Programs/Design 17.1.2 Market Size Estimation 17.1.3 Market Breakdown and Data Triangulation 17.2 Data Source 17.2.1 Secondary Sources 17.2.2 Primary Sources 17.3 Disclaimer
List of Tables and Figures Figure Product Picture of Neurological Disorder Drugs Figure Asia-Pacific Neurological Disorder Drugs Sales Volume (K Pcs) by Type (2013-2025) Figure Asia-Pacific Neurological Disorder Drugs Sales Volume Market Share by Type (Product Category) in 2017 Figure Antipsychotic Product Picture Figure Hypnotic & Sedative Product Picture Figure Analgesics Product Picture Figure Anticoagulants Product Picture Figure Others Product Picture Figure Asia-Pacific Neurological Disorder Drugs Sales (K Pcs) by Application (2013-2025) Figure Asia-Pacific Sales Market Share of Neurological Disorder Drugs by Application in 2017 Figure Hospital Examples Table Key Downstream Customer in Hospital Figure Clinic Examples Table Key Downstream Customer in Clinic Figure Home Examples Table Key Downstream Customer in Home Figure Asia-Pacific Neurological Disorder Drugs Market Size (Million USD) by Region (2013-2025) Figure China Neurological Disorder Drugs Revenue (Million USD) and Growth Rate (2013-2025) Figure Japan Neurological Disorder Drugs Revenue (Million USD) and Growth Rate (2013-2025) Figure South Korea Neurological Disorder Drugs Revenue (Million USD) and Growth Rate (2013-2025) Figure Taiwan Neurological Disorder Drugs Revenue (Million USD) and Growth Rate (2013-2025) Figure India Neurological Disorder Drugs Revenue (Million USD) and Growth Rate (2013-2025) Figure Southeast Asia Neurological Disorder Drugs Revenue (Million USD) and Growth Rate (2013-2025) Figure Australia Neurological Disorder Drugs Revenue (Million USD) and Growth Rate (2013-2025) Figure Asia-Pacific Neurological Disorder Drugs Sales Volume (K Pcs) and Growth Rate (2013-2025) Figure Asia-Pacific Neurological Disorder Drugs Revenue (Million USD) and Growth Rate (2013-2025) Figure Asia-Pacific Neurological Disorder Drugs Market Major Players Product Sales Volume (K Pcs)(2013-2018) Table Asia-Pacific Neurological Disorder Drugs Sales (K Pcs) of Key Players/Suppliers (2013-2018) Table Asia-Pacific Neurological Disorder Drugs Sales Share by Players/Suppliers (2013-2018) Figure 2017 Asia-Pacific Neurological Disorder Drugs Sales Share by Players/Suppliers Figure 2017 Asia-Pacific Neurological Disorder Drugs Sales Share by Players/Suppliers Figure Asia-Pacific Neurological Disorder Drugs Market Major Players Product Revenue (Million USD) 2013-2018 Table Asia-Pacific Neurological Disorder Drugs Revenue (Million USD) by Players/Suppliers (2013-2018) Table Asia-Pacific Neurological Disorder Drugs Revenue Share by Players/Suppliers (2013-2018) Figure 2017 Asia-Pacific Neurological Disorder Drugs Revenue Share by Players Figure 2017 Asia-Pacific Neurological Disorder Drugs Revenue Share by Players Table Asia-Pacific Neurological Disorder Drugs Sales and Market Share by Type (2013-2018) Table Asia-Pacific Neurological Disorder Drugs Sales Share by Type (2013-2018) Figure Sales Market Share of Neurological Disorder Drugs by Type (2013-2018) Figure Asia-Pacific Neurological Disorder Drugs Sales Growth Rate by Type (2013-2018) Table Asia-Pacific Neurological Disorder Drugs Revenue (Million USD) and Market Share by Type (2013-2018) Table Asia-Pacific Neurological Disorder Drugs Revenue Share by Type (2013-2018) Figure Revenue Market Share of Neurological Disorder Drugs by Type (2013-2018) Figure Asia-Pacific Neurological Disorder Drugs Revenue Growth Rate by Type (2013-2018) Table Asia-Pacific Neurological Disorder Drugs Sales Volume (K Pcs) and Market Share by Region (2013-2018) Table Asia-Pacific Neurological Disorder Drugs Sales Share by Region (2013-2018) Figure Sales Market Share of Neurological Disorder Drugs by Region (2013-2018) Figure Asia-Pacific Neurological Disorder Drugs Sales Market Share by Region in 2017 Table Asia-Pacific Neurological Disorder Drugs Revenue (Million USD) and Market Share by Region (2013-2018) Table Asia-Pacific Neurological Disorder Drugs Revenue Share (%) by Region (2013-2018) Figure Revenue Market Share of Neurological Disorder Drugs by Region (2013-2018) Figure Asia-Pacific Neurological Disorder Drugs Revenue Market Share by Region in 2017 Table Asia-Pacific Neurological Disorder Drugs Sales Volume (K Pcs) and Market Share by Application (2013-2018) Table Asia-Pacific Neurological Disorder Drugs Sales Share (%) by Application (2013-2018) Figure Asia-Pacific Neurological Disorder Drugs Sales Market Share by Application (2013-2018) Figure Asia-Pacific Neurological Disorder Drugs Sales Market Share by Application (2013-2018) Figure China Neurological Disorder Drugs Sales (K Pcs) and Growth Rate (2013-2018) Figure China Neurological Disorder Drugs Revenue (Million USD) and Growth Rate (2013-2018) Figure China Neurological Disorder Drugs Sales Price (USD/Pcs) Trend (2013-2018) Table China Neurological Disorder Drugs Sales Volume (K Pcs) by Type (2013-2018) Table China Neurological Disorder Drugs Sales Volume Market Share by Type (2013-2018) Figure China Neurological Disorder Drugs Sales Volume Market Share by Type in 2017 Table China Neurological Disorder Drugs Sales Volume (K Pcs) by Applications (2013-2018) Table China Neurological Disorder Drugs Sales Volume Market Share by Application (2013-2018) Figure China Neurological Disorder Drugs Sales Volume Market Share by Application in 2017 Figure Japan Neurological Disorder Drugs Sales (K Pcs) and Growth Rate (2013-2018) Figure Japan Neurological Disorder Drugs Revenue (Million USD) and Growth Rate (2013-2018) Figure Japan Neurological Disorder Drugs Sales Price (USD/Pcs) Trend (2013-2018) Table Japan Neurological Disorder Drugs Sales Volume (K Pcs) by Type (2013-2018) Table Japan Neurological Disorder Drugs Sales Volume Market Share by Type (2013-2018) Figure Japan Neurological Disorder Drugs Sales Volume Market Share by Type in 2017 Table Japan Neurological Disorder Drugs Sales Volume (K Pcs) by Applications (2013-2018) Table Japan Neurological Disorder Drugs Sales Volume Market Share by Application (2013-2018) Figure Japan Neurological Disorder Drugs Sales Volume Market Share by Application in 2017 Figure South Korea Neurological Disorder Drugs Sales (K Pcs) and Growth Rate (2013-2018) Figure South Korea Neurological Disorder Drugs Revenue (Million USD) and Growth Rate (2013-2018) Figure South Korea Neurological Disorder Drugs Sales Price (USD/Pcs) Trend (2013-2018) Table South Korea Neurological Disorder Drugs Sales Volume (K Pcs) by Type (2013-2018) Table South Korea Neurological Disorder Drugs Sales Volume Market Share by Type (2013-2018) Figure South Korea Neurological Disorder Drugs Sales Volume Market Share by Type in 2017 Table South Korea Neurological Disorder Drugs Sales Volume (K Pcs) by Applications (2013-2018) Table South Korea Neurological Disorder Drugs Sales Volume Market Share by Application (2013-2018) Figure South Korea Neurological Disorder Drugs Sales Volume Market Share by Application in 2017 Figure Taiwan Neurological Disorder Drugs Sales (K Pcs) and Growth Rate (2013-2018) Figure Taiwan Neurological Disorder Drugs Revenue (Million USD) and Growth Rate (2013-2018) Figure Taiwan Neurological Disorder Drugs Sales Price (USD/Pcs) Trend (2013-2018) Table Taiwan Neurological Disorder Drugs Sales Volume (K Pcs) by Type (2013-2018) Table Taiwan Neurological Disorder Drugs Sales Volume Market Share by Type (2013-2018) Figure Taiwan Neurological Disorder Drugs Sales Volume Market Share by Type in 2017 Table Taiwan Neurological Disorder Drugs Sales Volume (K Pcs) by Applications (2013-2018) Table Taiwan Neurological Disorder Drugs Sales Volume Market Share by Application (2013-2018) Figure Taiwan Neurological Disorder Drugs Sales Volume Market Share by Application in 2017 Figure India Neurological Disorder Drugs Sales (K Pcs) and Growth Rate (2013-2018) Figure India Neurological Disorder Drugs Revenue (Million USD) and Growth Rate (2013-2018) Figure India Neurological Disorder Drugs Sales Price (USD/Pcs) Trend (2013-2018) Table India Neurological Disorder Drugs Sales Volume (K Pcs) by Type (2013-2018) Table India Neurological Disorder Drugs Sales Volume Market Share by Type (2013-2018) Figure India Neurological Disorder Drugs Sales Volume Market Share by Type in 2017 Table India Neurological Disorder Drugs Sales Volume (K Pcs) by Application (2013-2018) Table India Neurological Disorder Drugs Sales Volume Market Share by Application (2013-2018) Figure India Neurological Disorder Drugs Sales Volume Market Share by Application in 2017 Figure Southeast Asia Neurological Disorder Drugs Sales (K Pcs) and Growth Rate (2013-2018) Figure Southeast Asia Neurological Disorder Drugs Revenue (Million USD) and Growth Rate (2013-2018) Figure Southeast Asia Neurological Disorder Drugs Sales Price (USD/Pcs) Trend (2013-2018) Table Southeast Asia Neurological Disorder Drugs Sales Volume (K Pcs) by Type (2013-2018) Table Southeast Asia Neurological Disorder Drugs Sales Volume Market Share by Type (2013-2018) Figure Southeast Asia Neurological Disorder Drugs Sales Volume Market Share by Type in 2017 Table Southeast Asia Neurological Disorder Drugs Sales Volume (K Pcs) by Applications (2013-2018) Table Southeast Asia Neurological Disorder Drugs Sales Volume Market Share by Application (2013-2018) Figure Southeast Asia Neurological Disorder Drugs Sales Volume Market Share by Application in 2017 Figure Australia Neurological Disorder Drugs Sales (K Pcs) and Growth Rate (2013-2018) Figure Australia Neurological Disorder Drugs Revenue (Million USD) and Growth Rate (2013-2018) Figure Australia Neurological Disorder Drugs Sales Price (USD/Pcs) Trend (2013-2018) Table Australia Neurological Disorder Drugs Sales Volume (K Pcs) by Type (2013-2018) Table Australia Neurological Disorder Drugs Sales Volume Market Share by Type (2013-2018) Figure Australia Neurological Disorder Drugs Sales Volume Market Share by Type in 2017 Table Australia Neurological Disorder Drugs Sales Volume (K Pcs) by Applications (2013-2018) Table Australia Neurological Disorder Drugs Sales Volume Market Share by Application (2013-2018) Figure Australia Neurological Disorder Drugs Sales Volume Market Share by Application in 2017 Table Novartis AG Neurological Disorder Drugs Basic Information List Table Novartis AG Neurological Disorder Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Novartis AG Neurological Disorder Drugs Sales (K Pcs) and Growth Rate (2013-2018) Figure Novartis AG Neurological Disorder Drugs Sales Market Share in Asia-Pacific (2013-2018) Figure Novartis AG Neurological Disorder Drugs Revenue Market Share in Asia-Pacific (2013-2018) Table GlaxoSmithKline plc Neurological Disorder Drugs Basic Information List Table GlaxoSmithKline plc Neurological Disorder Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure GlaxoSmithKline plc Neurological Disorder Drugs Sales (K Pcs) and Growth Rate (2013-2018) Figure GlaxoSmithKline plc Neurological Disorder Drugs Sales Market Share in Asia-Pacific (2013-2018) Figure GlaxoSmithKline plc Neurological Disorder Drugs Revenue Market Share in Asia-Pacific (2013-2018) Table Merck & Co. Neurological Disorder Drugs Basic Information List Table Merck & Co. Neurological Disorder Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Merck & Co. Neurological Disorder Drugs Sales (K Pcs) and Growth Rate (2013-2018) Figure Merck & Co. Neurological Disorder Drugs Sales Market Share in Asia-Pacific (2013-2018) Figure Merck & Co. Neurological Disorder Drugs Revenue Market Share in Asia-Pacific (2013-2018) Table Bayer AG Neurological Disorder Drugs Basic Information List Table Bayer AG Neurological Disorder Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Bayer AG Neurological Disorder Drugs Sales (K Pcs) and Growth Rate (2013-2018) Figure Bayer AG Neurological Disorder Drugs Sales Market Share in Asia-Pacific (2013-2018) Figure Bayer AG Neurological Disorder Drugs Revenue Market Share in Asia-Pacific (2013-2018) Table AstraZeneca Neurological Disorder Drugs Basic Information List Table AstraZeneca Neurological Disorder Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure AstraZeneca Neurological Disorder Drugs Sales (K Pcs) and Growth Rate (2013-2018) Figure AstraZeneca Neurological Disorder Drugs Sales Market Share in Asia-Pacific (2013-2018) Figure AstraZeneca Neurological Disorder Drugs Revenue Market Share in Asia-Pacific (2013-2018) Table Boehringer Ingelheim GmbH Neurological Disorder Drugs Basic Information List Table Boehringer Ingelheim GmbH Neurological Disorder Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Boehringer Ingelheim GmbH Neurological Disorder Drugs Sales (K Pcs) and Growth Rate (2013-2018) Figure Boehringer Ingelheim GmbH Neurological Disorder Drugs Sales Market Share in Asia-Pacific (2013-2018) Figure Boehringer Ingelheim GmbH Neurological Disorder Drugs Revenue Market Share in Asia-Pacific (2013-2018) Table Teva Pharmaceutical Industries Ltd. Neurological Disorder Drugs Basic Information List Table Teva Pharmaceutical Industries Ltd. Neurological Disorder Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Teva Pharmaceutical Industries Ltd. Neurological Disorder Drugs Sales (K Pcs) and Growth Rate (2013-2018) Figure Teva Pharmaceutical Industries Ltd. Neurological Disorder Drugs Sales Market Share in Asia-Pacific (2013-2018) Figure Teva Pharmaceutical Industries Ltd. Neurological Disorder Drugs Revenue Market Share in Asia-Pacific (2013-2018) Table Production Base and Market Concentration Rate of Raw Material Figure Price (USD/Pcs) Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Neurological Disorder Drugs Figure Manufacturing Process Analysis of Neurological Disorder Drugs Figure Neurological Disorder Drugs Industrial Chain Analysis Table Raw Materials Sources of Neurological Disorder Drugs Major Manufacturers in 2017 Table Major Buyers of Neurological Disorder Drugs Table Distributors/Traders List Figure Asia-Pacific Neurological Disorder Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025) Figure Asia-Pacific Neurological Disorder Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025) Figure Asia-Pacific Neurological Disorder Drugs Price (USD/Pcs) and Trend Forecast (2018-2025) Table Asia-Pacific Neurological Disorder Drugs Sales Volume (K Pcs) Forecast by Region (2018-2025) Figure Asia-Pacific Neurological Disorder Drugs Sales Volume Market Share Forecast by Region (2018-2025) Figure Asia-Pacific Neurological Disorder Drugs Sales Volume Market Share Forecast by Region in 2025 Table Asia-Pacific Neurological Disorder Drugs Revenue (Million USD) Forecast by Region (2018-2025) Figure Asia-Pacific Neurological Disorder Drugs Revenue Market Share Forecast by Region (2018-2025) Figure Asia-Pacific Neurological Disorder Drugs Revenue Market Share Forecast by Region in 2025 Figure China Neurological Disorder Drugs Sales (K Pcs) and Growth Rate Forecast (2018-2025) Figure China Neurological Disorder Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025) Figure Japan Neurological Disorder Drugs Sales (K Pcs) and Growth Rate Forecast (2018-2025) Figure Japan Neurological Disorder Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025) Figure South Korea Neurological Disorder Drugs Sales (K Pcs) and Growth Rate Forecast (2018-2025) Figure South Korea Neurological Disorder Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025) Figure Taiwan Neurological Disorder Drugs Sales (K Pcs) and Growth Rate Forecast (2018-2025) Figure Taiwan Neurological Disorder Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025) Figure India Neurological Disorder Drugs Sales (K Pcs) and Growth Rate Forecast (2018-2025) Figure India Neurological Disorder Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025) Figure Southeast Asia Neurological Disorder Drugs Sales (K Pcs) and Growth Rate Forecast (2018-2025) Figure Southeast Asia Neurological Disorder Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025) Figure Australia Neurological Disorder Drugs Sales (K Pcs) and Growth Rate Forecast (2018-2025) Figure Australia Neurological Disorder Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025) Table Asia-Pacific Neurological Disorder Drugs Sales (K Pcs) Forecast by Type (2018-2025) Figure Asia-Pacific Neurological Disorder Drugs Sales Market Share Forecast by Type (2018-2025) Table Asia-Pacific Neurological Disorder Drugs Revenue (Million USD) Forecast by Type (2018-2025) Figure Asia-Pacific Neurological Disorder Drugs Revenue Market Share Forecast by Type (2018-2025) Table Asia-Pacific Neurological Disorder Drugs Price (USD/Pcs) Forecast by Type (2018-2025) Table Asia-Pacific Neurological Disorder Drugs Sales (K Pcs) Forecast by Application (2018-2025) Figure Asia-Pacific Neurological Disorder Drugs Sales Market Share Forecast by Application (2018-2025) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.